<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To reveal the present status and future directions of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in Asia </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The Working Group consisted of oncologists from six Asian countries (Japan, Korea, Hong Kong, China, Taiwan, Singapore and Philippines) discussed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in the 30th Asia-Pacific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Conference and made a consensus report </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has been increasing rapidly in recent decades, and mortality has also increased except in Japan and Singapore </plain></SENT>
<SENT sid="3" pm="."><plain>Colorectal screening with fecal occult blood tests is a national policy in Taiwan, Japan and Korea </plain></SENT>
<SENT sid="4" pm="."><plain>Total colonoscopy is the most common examination for diagnosing <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>However, there are differences in the macroscopic classification used </plain></SENT>
<SENT sid="6" pm="."><plain>Laparoscopic surgery for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> is extensively used, although the indication varies </plain></SENT>
<SENT sid="7" pm="."><plain>Adequate lymph node harvesting of more than 12 nodes is performed in most countries </plain></SENT>
<SENT sid="8" pm="."><plain>Neoadjuvant <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> therapy is not routinely done for T2 or T3 <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Total mesorectal excision is the standard surgery for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Survival rate data are unavailable for many countries and should be compiled in <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The differences in the health-care delivery systems affect the treatment choices for unresectable <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Infusional 5-FU plus leucovorin plus <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (FOLFOX) is the most popular first-line regimen </plain></SENT>
<SENT sid="13" pm="."><plain>Cetuximab is mainly used as a second- or third-line regimen with reference to k-ras mutation </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi>-based adjuvant chemotherapy is commonly used for stage III disease, whereas the clinical practice for stage II disease varies </plain></SENT>
<SENT sid="15" pm="."><plain>CONCLUSIONS: Further clinical cooperation is needed to optimize the management of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in Asia </plain></SENT>
</text></document>